Middle East and Africa Hemostasis Diagnostics Market: Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

12/mar/2018 11:00:52 pbi Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Market Outline: Middle East and Africa Hemostasis Diagnostics Market 

Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.

 

Market Dynamics: Middle East and Africa Hemostasis Diagnostics Market

Increase in the prevalence of hemophilia disease in Middle East and Africa region (according to World Federation of Hemophilia Global Survey 2010, approximately 1,886 hemophilia cases were observed in South Africa), adoption of newer technologies by Middle East countries, and expansion of business by the market players into Middle East and Africa region are anticipated to fuel the hemostasis diagnostics market over the forecast period. However high cost of advanced hemostasis products and regulations bottlenecks for the test approvals are expected to hamper the growth of hemostasis diagnostics market.

 

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-hemostasis-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Market Scope: Middle East and Africa Hemostasis Diagnostics Market

Hemostasis diagnostics market is segmented on the basis of product type, test type, technology, and end user

Based on the product type, the market is segmented into the following:

·         Systems

·         Consumables

·         Point-of-Care Testing Devices

Based on the test type, the market is segmented into the following:

·         Fibrinogen Test

·         Activated Clotting Time

·         Platelet Function

·         Prothrombin Time

·         Heparin & Protamine Dose-Response Test For ACT

·         Activated Partial Thromboplastin Time

·         Anti-Factor Xa

·         Other Coagulation Tests

Based on the technology, the market is segmented into the following:

·         Optical

·         Mechanical

·         Electrochemical

·         Others

Based on the end user, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Diagnostic Centres

·         Others (POC)

 

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-hemostasis-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

 

 Regional Analysis: Middle East and Africa Hemostasis Diagnostics Market

Geographically, Middle East and Africa hemostasis diagnostics market is segmented into Gulf Cooperation Council (GCC) countries, Israel, South Africa, and rest of Middle East and Africa. South Africa hemostasis diagnostics market is growing due to increase in the prevalence of hemophilia disease, advances in healthcare infrastructure, and increase in per capita income are anticipated to propel the market. Moreover, expansion of business into MEA region by market players, and launching of newer products also expected to propel the growth of market over forecast years.

 

Competition Assessment: Middle East and Africa Hemostasis Diagnostics Market

Some of the players in the Middle East and Africa hemostasis diagnostics market include:

·         Hoffmann-La Roche Ltd. (Switzerland)

·         Sysmex Corporation (Japan)

·         Abbott Laboratories (U.S.)

·         Nihon Kohden Corporation (Japan)

·         Siemens Healthineers (Germany)

·         Grifols S.A (Spain)

·         Beckman Coulter, Inc. (U.S.)

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-hemostasis-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, and forecast from 2017-2023

·         The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies

·         The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry

·         The report tracks recent innovations, key developments and start-up’s details that are working in the industry

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/middle-east-and-africa-hemostasis-diagnostics-market/

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl